Compound Evidence File
#EC-2026-0390
Anavar (Oxandrolone) Raw
Filed under Raw Materials. The bureau holds 110 laboratory returns for this compound from 34 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
34 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 7 | 10.0 | 9.9 | 10.0 | 23 May 2026 | 23 May 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 10.0 | 9.9 | 10.0 | 26 Apr 2026 | 3 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 10.0 | 9.9 | 10.0 | 10 May 2026 | 2 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 9.9 | 10.0 | 4 Jan 2026 | 26 Apr 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 10.0 | 10.0 | 25 Dec 2025 | 26 Jul 2026 |
| Bulk Peptide WholesaleCASE #VI-2026-0319 | A | 2 | 10.0 | 10.0 | 10.0 | 6 May 2025 | 24 May 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 10.0 | 10.0 | 10.0 | 25 Mar 2026 | 24 Apr 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 4 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 9.9 | 9.9 | 10.0 | 27 Dec 2025 | 1 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 9.9 | 9.9 | 10.0 | 1 Jan 2026 | 5 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 9.9 | 9.9 | 10.0 | 21 Dec 2025 | 2 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 9.9 | 9.9 | 10.0 | 23 Mar 2026 | 9 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 9.9 | 9.9 | 10.0 | 11 Nov 2025 | 17 May 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 9.9 | 9.9 | 10.0 | 8 Mar 2026 | 24 Jul 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 9.9 | 9.9 | 9.9 | 25 Mar 2026 | 9 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 9.9 | 9.9 | 10.0 | 14 Mar 2026 | 9 Apr 2026 |
| Risynth BioCASE #VI-2026-0672 | X | 1 | 9.6 | 9.6 | 9.6 | 13 Feb 2025 | 13 Feb 2025 |
| The Naughty NeedleCASE #VI-2026-0432 | X | 1 | 9.5 | 9.5 | 9.5 | 24 Apr 2025 | 24 Apr 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 8 | 9.1 | 6.7 | 10.0 | 24 May 2026 | 24 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 5 | 8.9 | 7.0 | 10.0 | 25 May 2026 | 25 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 2 | 8.8 | 8.1 | 9.4 | 25 May 2026 | 25 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 6 | 8.7 | 7.5 | 10.0 | 21 May 2026 | 21 May 2026 |
| NUPEPS PeptidesCASE #VI-2026-0896 | X | 1 | 8.5 | 8.5 | 8.5 | 3 Jul 2025 | 3 Jul 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 5 | 8.2 | 7.2 | 9.2 | 23 May 2026 | 23 May 2026 |
| Xianhong Tong XHT PeptidesCASE #VI-2026-0997 | X | 1 | 7.9 | 7.9 | 7.9 | 14 Jan 2025 | 14 Jan 2025 |
| Xingruida XDRCASE #VI-2026-0898 | X | 6 | 7.8 | 6.2 | 9.6 | 20 Jun 2025 | 26 Jan 2026 |
| Qing Li PeptideCASE #VI-2026-0469 | X | 12 | 6.5 | 3.5 | 9.8 | 13 Feb 2025 | 24 May 2026 |
| OmegAminoCASE #VI-2026-0014 | X | 1 | 6.2 | 6.2 | 6.2 | 27 Feb 2025 | 27 Feb 2025 |
| Shanghai OuDaXin New Material Technology CenterCASE #VI-2026-0498 | E | 3 | 5.6 | 3.2 | 8.2 | 27 Feb 2025 | 24 May 2026 |
| Alimo PeptideCASE #VI-2026-0524 | X | 1 | 5.2 | 5.2 | 5.2 | 20 Jun 2025 | 20 Jun 2025 |
| Peptronix Bio PTBCASE #VI-2026-0979 | X | 1 | 5.0 | 5.0 | 5.0 | 24 Apr 2025 | 24 Apr 2025 |
| Yongkang Nuoao Trading CoCASE #VI-2026-0646 | X | 1 | 3.9 | 3.9 | 3.9 | 28 Mar 2025 | 28 Mar 2025 |
| PepKitsCASE #VI-2026-0320 | X | 1 | 1.6 | 1.6 | 1.6 | 27 Feb 2025 | 27 Feb 2025 |
| Lejian Biotech PeptideCASE #VI-2026-0746 | X | 1 | 0.5 | 0.5 | 0.5 | 14 Jan 2025 | 14 Jan 2025 |
Open any subject to view the batch-level evidence for Anavar (Oxandrolone) Raw alone.